Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Second-line Therapy (TASER-P)

This study has been completed.
amfAR, The Foundation for AIDS Research
Dr Cipto Mangunkusumo General Hospital
Pediatric Institute, Hospital Kuala Lumpur
Chiang Mai University
Srinagarind Hospital, Khon Kaen University
Mahidol University
Children's Hospital Number 1, Ho Chi Minh City, Vietnam
Children's Hospital Number 2, Ho Chi Minh City, Vietnam
The Kirby Institute for Infection and Immunity in Society
University of California, San Francisco
Information provided by (Responsible Party):
The HIV Netherlands Australia Thailand Research Collaboration Identifier:
First received: February 7, 2013
Last updated: May 9, 2016
Last verified: May 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2015
  Primary Completion Date: July 2015 (Final data collection date for primary outcome measure)